UPClytics
Alle Fälle anzeigen

UPC CFI 380/2024

3. Juli 2024·EP4201327 Einheitspatent · FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Verfahrensdetails
Status
Case ClosedIn der Berufung aufgehoben, 1. Mai 2025
Verfahrensart
Einstweilige Verfügung
Kategorie
Einstweilige Maßnahmen
Parteien
Kläger
Vertreter
Beklagte
Vertreter
Division
Milan CD
Technologie
  • Instruments
    Medical technology
Sprache
English
Erste Entscheidung
1. Okt. 2024
Letzte Entscheidung
22. Nov. 2024
EPA-Einspruch
  • EOFlow Co., Ltd.Zurückgenommen2025-03-18
  • KELLER SCHNEIDER PATENTANWALTS GMBHZulässig2025-03-19
  • Inspicos P/SZurückgenommen2025-03-19
Berufung
Im Vergleich
Die Bilanz des Gerichts für diese Art von Verfahren, gezählt in erstinstanzlichen Entscheidungen. Eine Zahl in Klammern gibt an, auf wie vielen Entscheidungen eine Quote beruht.
Einstweilige Verfügung erlassenMedian Tage bis zur ersten Entscheidung
Gesamt-UPC54% (38/70)124
Milan CDGesperrtGesperrt
Richter Andrea PostiglioneGesperrtGesperrt
Richter Anna-Lena KleinGesperrtGesperrt
Richter Uwe SchwengelbeckGesperrtGesperrt

Vor dem UPC: Insulet Corporation (25 Verfahren)·EOFLOW Co., Ltd. (19 Verfahren)

Dieser Streit umfasst 18 weitere Verfahren

UPC CFI 1230/2026·UPC CoA 34/2026·UPC CoA 930/2025·UPC CFI 1167/2025·UPC CFI 773/2025 und 13 weitere

3 weitere Beklagte zum selben oder einem verwandten Patent

UPC CFI 793/2024·UPC CoA 769/2024·UPC CFI 400/2024

Starten Sie die kostenlose Testphase, um die Ausgänge zu sehen.

Weitere Verfahren: Milan CD·2024

Entscheidungen
  • 2024-11-22
    Application for provisional measuresÖffentlich

    Zusammenfassung: The Milan Central Division rejected Insulet Corporation's application for a preliminary injunction against EOFLOW Co., Ltd. for alleged infringement of EP 4 201 327 (insulin pump). The Court held that the applicant had not established with sufficient certainty that the patent was valid (particularly claim 1 which appeared to lack novelty or inventive step over the prior art). The auxiliary request to amend the patent under R. 30.2 RoP was inadmissible in provisional measures proceedings given the requirement for expediency and the adversarial principle. Insulet was ordered to bear the costs; value in dispute EUR 2,500,000; cost ceiling EUR 400,000.

    Rechtsfragen anzeigen (4)
    • Provisional measures (R. 206 RoP; Art. 62 UPCA)
    • Validity of patent in provisional measures proceedings
    • Admissibility of patent amendment in provisional measures (R. 30.2 RoP)
    • Claim interpretation (R. 263.2 RoP)
  • 2024-10-01

    Zusammenfassung: Milan Central Division procedural order in provisional measures proceedings by Insulet Corporation against EOFlow Co. Ltd. concerning EP 4 201 327 (insulin pump). A. Menarini Diagnostics (exclusive distributor of EOFlow) applied to intervene. The Court rejected the intervention request, reasoning that interim injunction proceedings should not be burdened with interventions that could slow down the accelerated procedure, and Menarini could pursue its interests in subsequent merits proceedings.

    Rechtsfragen anzeigen (3)
    • Intervention in provisional measures proceedings (R. 313 RoP)
    • Third-party intervention by distributor
    • Insulin pump / wearable medical device technology
DokumenttitelDatumÖffentlich
Case Closure Formal Check2025-05-02Nicht öffentlich
Outcome of the Order2025-02-15Nicht öffentlich
ORDER 11 February 20252025-02-15Öffentlich
Receipt2025-01-31Nicht öffentlich
Rejoinder Cost Fixation Proceedings2025-01-31Nicht öffentlich
Rejoinder Cost Fixation Proceedings2025-01-31Nicht öffentlich
Exhibit PS C-62025-01-31Nicht öffentlich
ORDER2024-11-27Öffentlich
ORDER2024-11-27Öffentlich
ORDER2024-11-27Nicht öffentlich
Zusammenfassung in einfacher Sprache

Insulet Corporation (US), maker of OmniPod insulin pumps, applied for a preliminary injunction against EOFLOW Co. Ltd (South Korea) based on EP 4 201 327 (a patent for a fluid delivery device used in insulin pumps). The Milan Central Division denied the PI, finding that prior art US'994 disclosed all features of claim 1 with sufficient certainty to cast serious doubt on the patent's validity. Insulet's auxiliary request to amend the patent in PI proceedings was held inadmissible, and Insulet was ordered to bear costs.

Angenommene Argumente
Was das Gericht akzeptiert hat — nach Partei.
  • Patent EP 4 201 327 claim 1 is likely not novel in view of prior art US'994

    BeklagterRechtsgrundlage: Art. 54 EPC

    Hinweis: Court found that US'994 discloses all features of claim 1 of the patent at issue (fluid delivery device with rotating nut/clutch mechanism), negating validity with sufficient certainty to deny the PI.

  • Auxiliary request to amend patent under R. 30.2 RoP is inadmissible in provisional measures proceedings

    BeklagterRechtsgrundlage: R. 30.2 RoP; R. 263.2 RoP

    Hinweis: Court held that the expedient nature of PI proceedings, combined with adversarial principle and right of defence, makes patent amendments under R. 30 inadmissible; 'amend its case' in R. 263.2 refers only to pleadings, not patent claims.

Zurückgewiesene Argumente
Was das Gericht nicht akzeptiert hat — und warum.
  • US'994 contains unworkable embodiments and should not be read to disclose all features of claim 1

    KlägerRechtsgrundlage: Art. 54 EPC; general principles of claim interpretation

    Begründung: Court applied the principle that patent descriptions must be interpreted to make the invention workable; US'994 Fig. 4 and Fig. 5 disclose two distinct workable embodiments, and the keyhole feature does not render the device non-functional.

  • Court should permit patent amendment as auxiliary request to cure any validity defect

    KlägerRechtsgrundlage: R. 30.2 RoP; R. 263.2 RoP

    Begründung: Patent amendment under R. 30.2 RoP is inadmissible in PI proceedings; R. 263.2 RoP's 'amend its case' refers only to pleadings amendments.

Herangezogener Stand der Technik
Zitierte Schriften und die Rolle, die sie gespielt haben.
  • US'994 (US patent cited as prior art against EP 4 201 327 claim 1)Neuheitsschädlich
Hinweise zur Anspruchsauslegung

The court construed claim 1 of EP 4 201 327 as covering a fluid delivery device with a drive mechanism comprising a drive wheel, lead screw, plunger, threadable nut, and clutch configured to allow the nut to pass through when disengaged and grip the nut when engaged so the drive wheel rotates the nut to advance the plunger. The court found US'994 discloses two embodiments (Figs. 4 and 5) that between them cover all these features.